A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children

Shigella sonnei live vaccine candidate, WRSS1, which was previously evaluated in US, Israeli and Thai volunteers, was administered orally to Bangladeshi adults and children to assess its safety, clinical tolerability and immunogenicity. In a randomized, placebo-controlled, dose-escalation, age-desce...

詳細記述

保存先:
書誌詳細
出版年:Hum Vaccin Immunother
主要な著者: Raqib, Rubhana, Sarker, Protim, Zaman, K., Alam, Nur Haque, Wierzba, Thomas F., Maier, Nicole, Talukder, Kaisar, Baqui, Abdullah Hel, Suvarnapunya, Akamol E., Qadri, Firdausi, Walker, Richard I., Fix, Alan, Venkatesan, Malabi M.
フォーマット: Artigo
言語:Inglês
出版事項: Taylor & Francis 2019
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6663145/
https://ncbi.nlm.nih.gov/pubmed/30794051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1575165
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料